Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization

Lung granulomas are the pathologic hallmark of tuberculosis (TB). T cells are a major cellular component of TB lung granulomas and are known to play an important role in containment of Mycobacterium tuberculosis (Mtb) infection. We used cynomolgus macaques, a non-human primate model that recapitulates human TB with clinically active disease, latent infection or early infection, to understand functional characteristics and dynamics of T cells in individual granulomas. We sought to correlate T cell cytokine response and bacterial burden of each granuloma, as well as granuloma and systemic responses in individual animals. Our results support that each granuloma within an individual host is independent with respect to total cell numbers, proportion of T cells, pattern of cytokine response, and bacterial burden. The spectrum of these components overlaps greatly amongst animals with different clinical status, indicating that a diversity of granulomas exists within an individual host. On average only about 8% of T cells from granulomas respond with cytokine production after stimulation with Mtb specific antigens, and few “multi-functional” T cells were observed. However, granulomas were found to be “multi-functional” with respect to the combinations of functional T cells that were identified among lesions from individual animals. Although the responses generally overlapped, sterile granulomas had modestly higher frequencies of T cells making IL-17, TNF and any of T-1 (IFN-γ, IL-2, or TNF) and/or T-17 (IL-17) cytokines than non-sterile granulomas. An inverse correlation was observed between bacterial burden with TNF and T-1/T-17 responses in individual granulomas, and a combinatorial analysis of pair-wise cytokine responses indicated that granulomas with T cells producing both pro- and anti-inflammatory cytokines (e.g. IL-10 and IL-17) were associated with clearance of Mtb. Preliminary evaluation suggests that systemic responses in the blood do not accurately reflect local T cell responses within granulomas.

[1]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[2]  James A. Raleigh,et al.  Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates , 2008, Infection and Immunity.

[3]  Philana Ling Lin,et al.  Early Changes by 18Fluorodeoxyglucose Positron Emission Tomography Coregistered with Computed Tomography Predict Outcome after Mycobacterium tuberculosis Infection in Cynomolgus Macaques , 2014, Infection and Immunity.

[4]  Denise E. Kirschner,et al.  Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection , 2013, PloS one.

[5]  P. Klenerman,et al.  Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[7]  John Chan,et al.  What's good for the host is good for the bug. , 2005, Trends in microbiology.

[8]  M. Tameris,et al.  Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells , 2009, European journal of immunology.

[9]  J. Flynn,et al.  Pulmonary Tuberculosis in Monkeys , 2010 .

[10]  J. Ernst,et al.  Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. , 2003, Microbes and infection.

[11]  Vitaly V. Ganusov,et al.  Mtb-Specific CD27low CD4 T Cells as Markers of Lung Tissue Destruction during Pulmonary Tuberculosis in Humans , 2012, PloS one.

[12]  Alimuddin Zumla,et al.  Tuberculosis 2013 : 2 Tuberculosis biomarkers discovery : developments , needs , and challenges , 2013 .

[13]  Denise Kirschner,et al.  A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.

[14]  Xinchun Chen,et al.  Multifunctional CD4 T Cell Responses in Patients with Active Tuberculosis , 2012, Scientific Reports.

[15]  R. Adegbola,et al.  Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease , 2009, European journal of immunology.

[16]  J. Flynn,et al.  Tumor necrosis factor and tuberculosis. , 2007, The journal of investigative dermatology. Symposium proceedings.

[17]  J. Flynn,et al.  Macrophages and control of granulomatous inflammation in tuberculosis , 2011, Mucosal Immunology.

[18]  JoAnne L. Flynn,et al.  Understanding Latent Tuberculosis: A Moving Target , 2010, The Journal of Immunology.

[19]  J. Flynn,et al.  The protective immune response to Mycobacterium tuberculosis. , 1995, Current opinion in immunology.

[20]  M. Ernst,et al.  Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot , 2008, European Respiratory Journal.

[21]  K. Dheda,et al.  Correlation of Mycobacterium Tuberculosis Specific and Non-Specific Quantitative Th1 T-Cell Responses with Bacillary Load in a High Burden Setting , 2012, PloS one.

[22]  R. Koup,et al.  Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations , 2007, European journal of immunology.

[23]  C. Dye Global epidemiology of tuberculosis , 2006, The Lancet.

[24]  K. Ackermann A Color Atlas Of Comparative Pathology Of Pulmonary Tuberculosis , 2016 .

[25]  J. Flynn,et al.  Immune responses in tuberculosis. , 2000, Current opinion in immunology.

[26]  A. Myers,et al.  Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques , 2006, Infection and Immunity.

[27]  S. Lockhart,et al.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial , 2013, The Lancet.

[28]  V. Dartois,et al.  Comprar A Color Atlas Of Comparative Pathology Of Pulmonary Tuberculosis | F. Leong | 9781439835272 | CRC PRESS , 2010 .

[29]  J. Flynn,et al.  Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques. , 2008, AIDS research and human retroviruses.

[30]  J. Flynn,et al.  Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension , 2006, Cellular microbiology.

[31]  T. Ottenhoff,et al.  Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection , 2010, European journal of immunology.

[32]  A. Hill,et al.  Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice , 2008, The Journal of Immunology.

[33]  Denise E Kirschner,et al.  Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Flynn,et al.  In Situ Studyof Abundant Expression of Proinflammatory Chemokines and Cytokines inPulmonary Granulomas That Develop in Cynomolgus MacaquesExperimentally Infected with Mycobacteriumtuberculosis , 2003, Infection and Immunity.

[35]  J. Flynn Immunology of tuberculosis and implications in vaccine development. , 2004, Tuberculosis.

[36]  R. Wilkinson,et al.  Polyfunctional T cells in human tuberculosis , 2010, European journal of immunology.

[37]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[38]  P. Bardin,et al.  In Situ Production of Gamma Interferon, Interleukin-4, and Tumor Necrosis Factor Alpha mRNA in Human Lung Tuberculous Granulomas , 2000, Infection and Immunity.

[39]  R. Eberhardt,et al.  Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. , 2009, American journal of respiratory and critical care medicine.

[40]  JoAnne L. Flynn,et al.  Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model , 2009, Infection and Immunity.

[41]  J. Flynn,et al.  CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. , 2010, The Journal of infectious diseases.

[42]  A. O’Garra,et al.  The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.

[43]  JoAnne L. Flynn,et al.  Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens , 2013, Antimicrobial Agents and Chemotherapy.

[44]  Simeone Marino,et al.  TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. , 2010, Journal of theoretical biology.

[45]  Hannah P. Gideon,et al.  Latent tuberculosis: what the host “sees”? , 2011, Immunologic research.

[46]  J. Flynn,et al.  Differential Virulence and Disease Progression following Mycobacterium tuberculosis Complex Infection of the Common Marmoset (Callithrix jacchus) , 2013, Infection and Immunity.

[47]  J. Andersson,et al.  Local immune responses in human tuberculosis: learning from the site of infection. , 2012, The Journal of infectious diseases.

[48]  Robert M. DiFazio,et al.  IFN-γ from CD4 T Cells Is Essential for Host Survival and Enhances CD8 T Cell Function during Mycobacterium tuberculosis Infection , 2013, The Journal of Immunology.

[49]  A. Sher,et al.  Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. , 2011, Immunity.

[50]  D. Kirschner,et al.  The human immune response to Mycobacterium tuberculosis in lung and lymph node. , 2004, Journal of theoretical biology.

[51]  J. Flynn,et al.  Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  JoAnne L. Flynn,et al.  Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection , 2003, Infection and Immunity.

[53]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[54]  J. Flynn,et al.  Simian Immunodeficiency Virus-Induced Changes in T Cell Cytokine Responses in Cynomolgus Macaques with Latent Mycobacterium tuberculosis Infection Are Associated with Timing of Reactivation , 2011, The Journal of Immunology.

[55]  A. Myers,et al.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. , 2010, Arthritis and rheumatism.

[56]  C. Harding,et al.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors , 2010, Nature Reviews Microbiology.

[57]  R. Gopal,et al.  IL-17 in protective immunity to intracellular pathogens , 2010, Virulence.

[58]  B. Ryffel,et al.  TNF in host resistance to tuberculosis infection. , 2010, Current directions in autoimmunity.

[59]  Jin Hee Kim,et al.  Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms , 2013, The Journal of Immunology.

[60]  A. Cooper,et al.  IL-17 and Th17 cells in tuberculosis. , 2010, Cytokine & growth factor reviews.

[61]  Andrea De Maria,et al.  Immunology of Tuberculosis , 2014, Mediterranean journal of hematology and infectious diseases.

[62]  P. Klenerman,et al.  Dynamic Relationship between IFN-γ and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load1 , 2007, The Journal of Immunology.

[63]  Thomas Scriba,et al.  Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG , 2013, Tuberculosis.

[64]  J. Flynn,et al.  Role of Tl and T2 Cytokines in the Response to Mycobacterium tuberculosis , 1996, Annals of the New York Academy of Sciences.

[65]  Youjin Lee,et al.  The many faces of Th17 cells. , 2011, Current opinion in immunology.

[66]  L. Ramakrishnan Revisiting the role of the granuloma in tuberculosis , 2012, Nature Reviews Immunology.

[67]  H. Kornfeld,et al.  Interferon-γ Regulates the Death of M. tuberculosis-Infected Macrophages , 2010, Journal of cell death.

[68]  Robert J Wilkinson,et al.  The immune response in tuberculosis. , 2013, Annual review of immunology.

[69]  J. Flynn,et al.  Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. , 2012, The American journal of pathology.